Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

Por Aoyama, Toru, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado no Oncol Lett (2017)

Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy

Por Aoyama, Toru, Kazama, Keisuke, Miyagi, Yohei, Murakawa, Masaaki, Yamaoku, Koichiro, Atsumi, Yosuke, Shiozawa, Manabu, Ueno, Makoto, Morimoto, Manabu, Oshima, Takashi, Yukawa, Norio, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado no Oncol Lett (2017)

The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas

Por Murakawa, Masaaki, Aoyama, Toru, Asari, Masahiro, Katayama, Yusuke, Yamaoku, Koichiro, Kanazawa, Amane, Higuchi, Akio, Shiozawa, Manabu, Kobayashi, Satoshi, Ueno, Makoto, Morimoto, Manabu, Yamamoto, Naoto, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado no BMC Surg (2015)

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy

Por Murakawa, Masaaki, Aoyama, Toru, Miyagi, Yohei, Atsumi, Yosuke, Kazama, Keisuke, Yamaoku, Koichiro, Kanazawa, Amane, Shiozawa, Manabu, Kobayashi, Satoshi, Ueno, Makoto, Morimoto, Manabu, Yamamoto, Naoto, Oshima, Takashi, Yoshikawa, Takaki, Rino, Yasushi, Masuda, Munetaka, Morinaga, Soichiro
Publicado no Oncol Lett (2017)